Association analysis of candidate genes for neuropsychiatric disease: The perpetual campaign

Trends in Genetics

Volumn 18, Issue 6, 2002, Pages 307-312

  Glatt, Charles E ^a   Freimer, Nelson B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN TRANSPORTER;

ALLELE; BRAIN; DNA POLYMORPHISM; GENE EXPRESSION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC TRAIT; GENOTYPE; HUMAN; HYPOTHESIS; MENTAL DISEASE; NEUROPSYCHIATRY; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; VALIDATION PROCESS;

DATA INTERPRETATION, STATISTICAL; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MENTAL DISORDERS;

EID: 0036607381     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-9525(02)02670-7     Document Type: Review

References (35)

1. Biological markers in psychiatry
2. Searching for genetic determinants in the new millennium
3. The geneticist's approach to complex disease
4. Positional cloning moves from perditional to traditional
5. Importance of quantitative genetic variations in the etiology of hypertension
6. Variations on a theme: Cataloging human DNA sequence variation
7. The new genomics: Global views of biology
8. The future of genetic studies of complex human diseases
9. Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology
10. Peripheral markers in anxiety and depression
11. Neurochemical individuality: Genetic diversity among human dopamine and serotonin receptors and transporters
12. History and evolution of the monoamine hypothesis of depression
13. The normal hemoglobins and the hemoglobinopathies: Background
14. Biological markers of depression
15. Pharmacological profile of antidepressants and related compounds at human monoamine transporters
16. Serotonergic mechanisms and the new antidepressants
17. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders
18. Allelic variation of human serotonin transporter gene expression
19. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
20. Comprehensive mutation screening in a cystic fibrosis center
21. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population
22. Molecular genetics of Parkinson's disease
23. Update on the molecular genetics of retinitis pigmentosa
24. Population choice in mapping genes for complex diseases
25. Use of population isolates for mapping complex traits
26. Psychiatric genetics: Search for phenotypes
27. Cerebrospinal fluid corticotropin-releasing hormone levels are elevated in monkeys with patterns of brain activity associated with fearful temperament
28. The genetics of essential hypertension
29. Variability and validity of polymorphism association studies in Parkinson's disease
30. Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding
31. Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests
32. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia
33. Genes for normal behavioral variation: Recent clues from flies and worms
34. Analysing uncharted transcriptomes with SAGE
35. Can 'differential display' methodologies make an impact on biological psychiatry?